Utilize este identificador para referenciar este registo: http://hdl.handle.net/10451/32305
Registo completo
Campo DCValorIdioma
degois.publication.firstPage555pt_PT
degois.publication.issue9pt_PT
degois.publication.lastPage560pt_PT
degois.publication.titleRevista Portuguesa de Cardiologíapt_PT
dc.relation.publisherversionhttps://www.sciencedirect.com/journal/revista-portuguesa-de-cardiologiapt_PT
dc.contributor.authorCaldeira, Daniel-
dc.contributor.authorBarra, Márcio-
dc.contributor.authorDavid, Cláudio-
dc.contributor.authorCosta, João-
dc.contributor.authorFerreira, Joaquim J.-
dc.contributor.authorPinto, Fausto J.-
dc.date.accessioned2018-03-13T15:42:52Z-
dc.date.available2018-03-13T15:42:52Z-
dc.date.issued2014-09-
dc.identifier.citationRev Port Cardiol. 2014;33(9):555-560pt_PT
dc.identifier.issn0870-2551-
dc.identifier.urihttp://hdl.handle.net/10451/32305-
dc.description© 2014 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. All rights reserved.pt_PT
dc.description.abstractIntroduction and Objectives: Oral anticoagulation (OAC) is an effective treatment in the prevention of thromboembolic events in patients with atrial fibrillation (AF). The aim of this review was to estimate the prevalence of OAC therapy in patients with AF in Portugal. Methods: MEDLINE, the Index of Portuguese Medical Journals and SIBUL (the Bibliographic Catalog of the Integrated Library System of the University of Lisbon) were searched for Portuguese observational studies reporting the proportion of anticoagulated patients with AF. The pooled estimated prevalence of anticoagulated patients and respective 95% confidence interval (CI) were determined by means of a meta-analysis. Results: Seven studies were included for analysis, of which four were conducted in a hospital environment and three in the general community. These studies enrolled a total of 891 patients with AF. The pooled estimated prevalence of anticoagulated patients was 40% (95% CI: 32---48%). Conclusions: The prevalence of OAC in Portuguese AF patients is low. There is a need to promote change in OAC prescribing habits for AF patients in Portugal, in accordance with international guidelines.pt_PT
dc.language.isoengpt_PT
dc.publisherElsevierpt_PT
dc.rightsopenAccesspt_PT
dc.subjectAtrial fibrillationpt_PT
dc.subjectAnticoagulationpt_PT
dc.subjectPrevalencept_PT
dc.subjectCoumarinspt_PT
dc.subjectWarfarinpt_PT
dc.subjectVitamin K antagonistspt_PT
dc.titleThe prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studiespt_PT
dc.title.alternativePrevalência da anticoagulação oral em doentes com fibrilhação auricular em Portugal : revisão sistemática e meta-análise de estudos observacionaispt_PT
dc.typearticlept_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.peerreviewedyespt_PT
degois.publication.volume33pt_PT
dc.identifier.doi10.1016/j.repc.2014.02.014pt_PT
Aparece nas colecções:IMM - Artigos em Revistas Nacionais
FM-CEMBE-Artigos em Revistas Nacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Prevalence_oral_anticoagulation.pdf170,88 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.